0001161697-24-000100.txt : 20240216
0001161697-24-000100.hdr.sgml : 20240216
20240216170037
ACCESSION NUMBER: 0001161697-24-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elsbernd Brian
CENTRAL INDEX KEY: 0001763511
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24649280
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 02-15-2024
X0508
4
2024-02-15
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001763511
Elsbernd Brian
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Compliance/Legal Officer
0
Common Stock, par value $0.001 per share
2024-02-15
4
M
0
9667
A
151786
D
Common Stock, par value $0.001 per share
2024-02-15
4
F
0
2353
D
149433
D
Restricted Stock Units
2024-02-15
4
M
0
9667
0
D
Common Stock
9667
1012823
D
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 15, 2024.
/s/ Brian Elsbernd
2024-02-16